Научная литература
booksshare.net -> Добавить материал -> Медицина -> Насонов Е.Л. -> "Антифосфолипидный синдром" -> 120

Антифосфолипидный синдром - Насонов Е.Л.

Насонов Е.Л. Антифосфолипидный синдром — М.: Литтерра, 2004. — 440 c.
ISBN 5-98216-010-5
Скачать (прямая ссылка): antisindrom2004.pdf
Предыдущая << 1 .. 114 115 116 117 118 119 < 120 > 121 122 123 124 125 126 .. 184 >> Следующая

64. Sshonbeck U, Varo N, Libby P, Buring J, Ridler PM. Soluble CD40L and cardiovascular risk in women. Circulation 2001; 104: 2266— 2268.
65. Heescher C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acure coronary syndrome. New Engl J Med 2003; 348:1104—1111.
66. Varo N, de Lemos JA, Libby P, et al. Soluble CD40L. Risl prediction after acute coronary syndrome. Circulation 2003; 108: 1049—1052.
67. Gearing A, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506—512.
68. Насонов ЕЛ, Баранов АА, Шилкина НП. Маркеры активации эндотелия (тром-бомодулин, антиген фактора Виллебранда и ангиотензинпревращающий фермент): клиническое значение. Клин. медицина, 1998; 11: 4—10.
69. Mannucci PM. Von Willebrand factor. A marker of endothelial damage? Arteriolscler Thromb Vasc Biol 1998; 18: 1359—1362.
70. Jang Y, Lincoff A, Plow E, Topol E. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 1994; 24: 1591—1601.
71. Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med 1999; 107: 85—97.
72. Blann AD, Lip GYH. Cell adhesion molecules in cardiovascular disease and its risk factors — what can soluble levels tell us? J Clin Endocrinol Metab 2000; 85: 1745—1747.
73. Virmani R, Kolodgie FD, Burke AP, et al. Inflammation and coronary arthery disease. In: Inflammation and cardiac disease. Ed. Feuerstein GZ, Kibby P, Mann DL. 2003. Birkhauser Verlag, 21—56.
74. Hillis GS, Flapan AD. Cell adhesion molecules in cardiovascular disease: a clinical perspectives. Heart 1998; 79: 429—431.
75. Frijns CJM. Kapppelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascu-lar disease. Stroke 2002; 33: 2115—2122.
76. Price CJS, Warburton EA, Menon DK. Human cellular inflammation in the pathology of acute cerebral ischemia. J Neurol Neurosurg Psychiatry 2003; 74: 1476—1484.
77. Ridker PM, Hennekers C, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88—92.
78. Hwang S-J, Ballantyne CB, SharrettAR, et al. Circulating adhesion molecules VACM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incidental coronary heart disease cases. The Atherosclerosis risk in communities (ARIC) study. Circulation 1997; 96: 4219—4225.
79. Blankenberg S, Rupprecht H-J, Bickel C, et al. Level of vascular cell adhesion molecule (sVCAM) and soluble intercellular adhesion molecule (sICAM) predicr future cardiovascular mortality and myocardial infarction in patients with angina pectoris. Circulation 2000; 102 (Supp l): II—777.
80. Peter K, Nawroth P, Conradt C, et al. Circulating vascular adhesion molecule-1 correlated with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, Р-selectin, and trombomod-ulin. Arteriosclscler Thromb Vasc Biol 1997; 17: 505—512.
81. Rohde LE, Lee RT, Rivero J, et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arteriosccl Thomb Vasc Biol 1998; 8: 1765—1770.
82. de Caterina R, Basta G, Lazzerini G, et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arteriolsckler Thromb Vasc Biol 1997; 7: 2646—2654.
83. Malik IC, Danesh J, Papacosta O, et al. Prognostic value of soluble adhesion molecules in predicting future CHD events: prospective data
SHS-OOO4.qxd 21.11.2006 16:56 Page 2997
Q-
ГЛАВА 11. Иммунологические маркеры атеросклероза
from British Regional Heart Study. Circulation 2000; 102 (Suppl). II—865.
84. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491—495.
85. Mulvhill NT, Foley JB, Murphy R et al. Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 2000; 36: 1210—1216.
86. Ghaisas NK, Shahi CN, Foley B, et al. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Amer J Cardiol 1997; 80: 617—619.
87. Gurbel P, Serebruany VL. Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolitic agents. Am J Cardiol 1998; 81: 772—775.
88. Miva K, Igawa A, Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 in systemic coronary circulation in patients with variant angina. Cardiovasc Res 1997; 36: 37—44.
89. Blann AD. McCollum CN. Increased levels of soluble adhesion molecules in atherosclerosis. Thromb Haemostas 1994; 72: 151—154.
90. Blann AD, Seigneur M, Steiner M, et al. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterinemia: relationship to the location of atherosclerosic disease, smoking, and in the prediction of adverse events. Thromb Haemost 1998; 79: 1080—1085.
91. Blann AD, Arniral J, McCollum CN. Soluble endothelial cell markers and adhesion molecules in ischaemic heart disease. Br J Haematol 1996; 95: 263—265.
Предыдущая << 1 .. 114 115 116 117 118 119 < 120 > 121 122 123 124 125 126 .. 184 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed